☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Sarepta Signs an Exclusive Global (Except EU) License Agreement with Lysogene for LYS-SAF302 to Treat MPS IIIA
October 16, 2018
Amgen Launches Amgevita (adalimumab- biosimilar) in EU to Treat Inflammatory Diseases post EMA Approval in Feb 2017
October 16, 2018
Novartis Reports Results of Five-year P-III MEASURE 1 and FUTURE 1 study for AS and PsA
October 16, 2018
Google Developed AI System for Easy Detection of Last Stage Breast Cancer with 99% Accuracy
October 16, 2018
AstraZeneca's Lynparza (olaparib) Receives Fourth FDA's Orphan Drug Designation to Treat Pancreatic Cancer
October 16, 2018
Regeneron's Dupixent (Dupilumab) Achieves 1EP & 2EP in two P-III trial for Inadequately-Controlled Chronic Rhinosinusitis with...
October 16, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions